Results 251 to 260 of about 75,185 (305)
Some of the next articles are maybe not open access.
Journal of Forensic Sciences, 1972
Abstract The medical therapy for Parkinson's disease, especially in younger patients, has recently included L-DOPA, the generic name for levodihydroxyphenylalanine. The prescribed therapeutic amounts of this drug have been suggested and the resulting circulating blood concentrations documented [1].
WQ Sturner, JC Garriott
openaire +1 more source
Abstract The medical therapy for Parkinson's disease, especially in younger patients, has recently included L-DOPA, the generic name for levodihydroxyphenylalanine. The prescribed therapeutic amounts of this drug have been suggested and the resulting circulating blood concentrations documented [1].
WQ Sturner, JC Garriott
openaire +1 more source
Microbiological Synthesis of L-dopa
Journal of Pharmaceutical Sciences, 1974The ability of microorganisms to convert N-carbobenzoxyl-L-tyrosine, N-tert-butyloxycarbonyl-L-tyrosine, and N-formyl-L-tyrosine into their respective N-substituted L-dopa derivatives was studied. These tyrosine derivatives were examined because of the ease with which the blocking groups may be removed.
J, Rosazza +3 more
openaire +2 more sources
l-dopa and pancreatic secretion
Biochemical Pharmacology, 1973Abstract Greengard , Roback and Ivy (1942) first observed that epinine ( N -methyldopamine), dopamine (dihydroxyphenylethylamine) and few phenylethylamine derivatives given intravenously stimulated the canine pancreatic secretion, while the majority of sympathomimetic amines tested inhibited it.
KOROKU HASHIMOTO +2 more
openaire +1 more source
Delayed l-DOPA-induced hyperalgesia
Pharmacology Biochemistry and Behavior, 2006Previously we reported on L-DOPA's antinociceptive effect on substance P-induced nociceptive behaviors in mice [Shimizu T, Iwata S, Morioka H, Masuyama T, Fukuda T, Nomoto M. Antinociceptive mechanism of L-DOPA. Pain 2004;110;246-9.]. Since significant hyperalgesia was noted following antinociception, our study was designed to investigate the mechanism
T, Shimizu +4 more
openaire +2 more sources
Parkinsonism, L-Dopa and Intelligence
American Journal of Psychiatry, 1973Although many patients with parkinsonism undergo a significant amount of intellectual impairment, several investigators, including the authors, have observed an improvement in intellectual functioning during the first year of treatment with L-dopa. Upon reexamining subjects after 30 months of treatment, however, the authors found that most of their ...
A W, Loranger +4 more
openaire +2 more sources
Science News, 1968
Brookhaven National Laboratory Parkinsonism patient before and after administration of L-dopa. In a confidential application for funds to the National Institutes of Health, a group of doctors proposes a study by 20 different institutions across the couLntry of the mysteriouLs drug L-dopa, which is apparently effective against Parkinson's disease.
openaire +1 more source
Brookhaven National Laboratory Parkinsonism patient before and after administration of L-dopa. In a confidential application for funds to the National Institutes of Health, a group of doctors proposes a study by 20 different institutions across the couLntry of the mysteriouLs drug L-dopa, which is apparently effective against Parkinson's disease.
openaire +1 more source